spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alkemade, J. A.
Right arrow Articles by Schalkwijk, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alkemade, J. A.
Right arrow Articles by Schalkwijk, J.

Journal of Cell Science, Vol 107, Issue 8 2335-2342, Copyright © 1994 by Company of Biologists

JOURNAL ARTICLES

SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes

JA Alkemade, HO Molhuizen, M Ponec, JA Kempenaar, PL Zeeuwen, GJ de Jongh, IM van Vlijmen-Willems, PE van Erp, PC van de Kerkhof and J Schalkwijk
Department of Dermatology, University Hospital Nijmegen, The Netherlands.

Skin-derived antileukoproteinase (SKALP), otherwise known as elafin, is a recently discovered epidermal proteinase inhibitor with specificity for polymorphonuclear leukocyte (PMN)-derived elastase and proteinase-3; in addition to the proteinase-inhibiting domain, SKALP contains several transglutaminase substrate motifs. SKALP is virtually absent in normal human epidermis but is found in a number of inflammatory skin diseases, including psoriasis. Here we report the induction and processing of SKALP in vivo and in vitro. SKALP expression in vivo could be demonstrated following injury in normal human epidermis, using histology, western blotting, northern blotting and a functional assay. In vitro, SKALP expression was studied in conventional submerged keratinocyte culture systems and in keratinocytes cultured in an air-liquid interface model. Induction of SKALP activity in epidermis could be measured as early as 16 hours after skin injury; immunohistological examination showed that SKALP expression was confined to the outer layers of the stratum spinosum and the stratum granulosum. Northern blot analysis revealed a 0.8 kb transcript, both in vivo (psoriatic skin, injured skin) and in vitro (cultured keratinocytes). Western blot analysis showed that the major SKALP form in vivo was a low molecular mass fragment, containing the antiproteinase domain. In all cultures that were positive for SKALP, larger (8-10 kDa) forms of SKALP, containing the N-terminal transglutaminase substrate motifs in addition to the antiproteinase domain, were found. SKALP expression in cultured cells was found to be dependent on the system used. In a submerged culture system, SKALP could be induced by fetal calf serum.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
N. Guyot, M. W. Butler, P. McNally, S. Weldon, C. M. Greene, R. L. Levine, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney
Elafin, an Elastase-specific Inhibitor, Is Cleaved by Its Cognate Enzyme Neutrophil Elastase in Sputum from Individuals with Cystic Fibrosis
J. Biol. Chem., November 21, 2008; 283(47): 32377 - 32385.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Z. Wang, D. Beach, L. Su, R. Zhai, and D. C. Christiani
A Genome-Wide Expression Analysis in Blood Identifies Pre-Elafin as a Biomarker in ARDS
Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 724 - 732.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
K. Yamasaki, J. Schauber, A. Coda, H. Lin, R. A. Dorschner, N. M. Schechter, C. Bonnart, P. Descargues, A. Hovnanian, and R. L. Gallo
Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin
FASEB J, October 1, 2006; 20(12): 2068 - 2080.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Hagiwara, T. Kikuchi, Y. Endo, Huqun, K. Usui, M. Takahashi, N. Shibata, T. Kusakabe, H. Xin, S. Hoshi, et al.
Mouse SWAM1 and SWAM2 Are Antibacterial Proteins Composed of a Single Whey Acidic Protein Motif
J. Immunol., February 15, 2003; 170(4): 1973 - 1979.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
A. Pol, F. Van Ruissen, and J. Schalkwijk
Development of a Keratinocyte-Based Screening Model for Antipsoriatic Drugs Using Green Fluorescent Protein Under the Control of an Endogenous Promoter
J Biomol Screen, August 1, 2002; 7(4): 325 - 332.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
P. L. J. M. Zeeuwen, W. Hendriks, W. W. de Jong, and J. Schalkwijk
Identification and Sequence Analysis of Two New Members of the SKALP/elafin and SPAI-2 Gene Family. BIOCHEMICAL PROPERTIES OF THE TRANSGLUTAMINASE SUBSTRATE MOTIF AND SUGGESTIONS FOR A NEW NOMENCLATURE
J. Biol. Chem., August 15, 1997; 272(33): 20471 - 20478.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. E. Hagstrom, M. P. Fautsch, M. Perdok, A. Vrabel, and E. D. Wieben
Exons Lost and Found. UNUSUAL EVOLUTION OF A SEMINAL VESICLE TRANSGLUTAMINASE SUBSTRATE
J. Biol. Chem., August 30, 1996; 271(35): 21114 - 21119.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. C. Ng, S. Shafaee, D. Lee, and D. D. Bikle
Requirement of an AP-1 Site in the Calcium Response Region of the Involucrin Promoter
J. Biol. Chem., July 28, 2000; 275(31): 24080 - 24088.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 1994